Jasper Therapeutics Inc
NASDAQ:JSPR
Income Statement
Earnings Waterfall
Jasper Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-68.9m
USD
|
Operating Income
|
-68.9m
USD
|
Other Expenses
|
4.4m
USD
|
Net Income
|
-64.5m
USD
|
Income Statement
Jasper Therapeutics Inc
Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||
Operating Expenses |
(27)
|
(31)
|
(37)
|
(43)
|
(47)
|
(50)
|
(51)
|
(52)
|
(58)
|
(65)
|
(69)
|
|
Selling, General & Administrative |
(8)
|
(9)
|
(11)
|
(14)
|
(15)
|
(16)
|
(17)
|
(16)
|
(17)
|
(18)
|
(17)
|
|
Research & Development |
(19)
|
(21)
|
(25)
|
(29)
|
(32)
|
(34)
|
(35)
|
(36)
|
(41)
|
(47)
|
(52)
|
|
Operating Income |
(27)
N/A
|
(31)
-15%
|
(37)
-20%
|
(43)
-18%
|
(47)
-8%
|
(50)
-6%
|
(51)
-3%
|
(52)
-2%
|
(58)
-11%
|
(65)
-11%
|
(69)
-6%
|
|
Pre-Tax Income | ||||||||||||
Interest Income Expense |
(12)
|
(8)
|
(4)
|
0
|
(0)
|
0
|
0
|
1
|
3
|
4
|
5
|
|
Total Other Income |
0
|
7
|
10
|
20
|
22
|
16
|
14
|
2
|
0
|
(0)
|
(1)
|
|
Pre-Tax Income |
(39)
N/A
|
(32)
+19%
|
(31)
+3%
|
(23)
+25%
|
(25)
-9%
|
(34)
-34%
|
(38)
-12%
|
(50)
-32%
|
(55)
-11%
|
(61)
-10%
|
(64)
-6%
|
|
Net Income | ||||||||||||
Income from Continuing Operations |
(39)
|
(32)
|
(31)
|
(23)
|
(25)
|
(34)
|
(38)
|
(50)
|
(55)
|
(61)
|
(64)
|
|
Net Income (Common) |
(39)
N/A
|
(32)
+19%
|
(31)
+3%
|
(23)
+25%
|
(25)
-9%
|
(34)
-34%
|
(38)
-12%
|
(50)
-32%
|
(55)
-11%
|
(61)
-10%
|
(64)
-6%
|
|
EPS (Diluted) |
-1.03
N/A
|
-0.83
+19%
|
-0.81
+2%
|
-0.63
+22%
|
-0.68
-8%
|
-0.91
-34%
|
-1.03
-13%
|
-0.56
+46%
|
-0.5
+11%
|
-0.55
-10%
|
-6.18
-1 024%
|